Status:

COMPLETED

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Lead Sponsor:

Finnish Institute for Health and Welfare

Collaborating Sponsors:

Finnish Foundation for Alcohol Studies

Conditions:

Alcoholism

Depression

Eligibility:

All Genders

25-70 years

Phase:

PHASE4

Brief Summary

The aim of the present study was to examine the influence of memantine, a noncompetitive NMDA receptor blocker, in depression co-morbid with long term alcohol heavy use comparing to SSRI-inhibitor, es...

Detailed Description

Context Depression is common clinical problem among alcoholics and its treatment has no standard and is controversy. Glutamate NMDA-receptors may mediate the effects of long term alcohol related depre...

Eligibility Criteria

Inclusion

  • The subject/patient is able to read and understand the subject/patient information sheet.
  • Prior to any screening procedures, the subject/patient must have signed the informed consent form. No study-related procedures may be performed before the subject/patient has signed the form.
  • Age 25-70 years
  • Heavy alcohol consumption (males more than 5 doses/ day, female more than 4 doses/day) for at least 10 years
  • Alcohol dependence (DSM-IV) assessed by SCID-I interview.
  • Major depression (DSM-IV) assessed by SCID-I interview. At least 4 weeks past from the previous inpatient treatment for AWS (alcohol withdrawal syndrome).

Exclusion

  • Other drug dependence (screened by urine test)
  • Other serious mental illness (DSM-IV)
  • Hazard of suicide
  • Pregnancy
  • Serious kidney, hart or thyroid problem
  • The subject/patient, in the opinion of the investigator, is unlikely to comply with the clinical study protocol or is unsuitable for any reason.
  • Liver cirrhosis or liver enzymes ASAT tai ALAT \>200.
  • The person that met the criteria stated in the Finnish Law on Clinical Studies, paragraph 7-10§ (children, pregnant, imamates or mentally handicapped).

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

End Date :

June 1 2006

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00368862

Start Date

December 1 2005

End Date

June 1 2006

Last Update

August 29 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Public Health Institute, Department of Mental Health and Alcohol Research

Helsinki, POB 33, Finland, 00251